Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria
Haghiri A. et al, (2023), Clinical Pharmacology & Therapeutics
Clinical needs assessment to inform development of a new assay to detect antimalarial drugs in patient samples: A case study
Coonahan ES. et al, (2023), PLOS Global Public Health, 3, e0002087 - e0002087
Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
Yipsirimetee A. et al, (2023), Antimicrobial agents and chemotherapy, 67
Ivermectin metabolites reduce Anopheles survival.
Kobylinski KC. et al, (2023), Scientific reports, 13
Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening
Carucci M. et al, (2023), Nature Communications, 14
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus
Varghese GM. et al, (2023), New England Journal of Medicine, 388, 792 - 803
Mass Spectrometry-Based Metabolomics Revealed Effects of Metronidazole on Giardia duodenalis.
Popruk S. et al, (2023), Pharmaceuticals (Basel, Switzerland), 16
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera DO. et al, (2023), Science translational medicine, 15
Untargeted serum metabolomics analysis of Trichinella spiralis-infected mouse.
Chienwichai P. et al, (2023), PLoS neglected tropical diseases, 17
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study
Flower B. et al, (2023), eLife, 12
Erratum for Banda et al., “Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV”
Banda CG. et al, (2023), Antimicrobial Agents and Chemotherapy
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
Watson JA. et al, (2022), eLife, 11
Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry
Hanpithakpong W. et al, (2022), Malaria Journal, 21
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
Dahal P. et al, (2022), Malaria Journal, 21
Cardiovascular concentration–effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies
Chan XHS. et al, (2022), British Journal of Clinical Pharmacology
Gut bacteriome and metabolome of Ascaris lumbricoides in patients.
Klomkliew P. et al, (2022), Scientific reports, 12